SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-028082
Filing Date
2022-02-28
Accepted
2022-02-28 16:14:31
Documents
13
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm227780d2_8k.htm   iXBRL 8-K 26111
2 EXHIBIT 99.1 tm227780d2_ex99-1.htm EX-99.1 110160
  Complete submission text file 0001104659-22-028082.txt   322858

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocul-20220228.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20220228_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20220228_pre.xml EX-101.PRE 22589
7 EXTRACTED XBRL INSTANCE DOCUMENT tm227780d2_8k_htm.xml XML 3491
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 22689708
SIC: 2834 Pharmaceutical Preparations